Holleigh Vella

Share

Holleigh faced a life-altering diagnosis on September 6th, 2022, at the age of 38, when she was informed about her stage 3 triple negative breast cancer with lymph node involvement. Genetic testing revealed that she carried a harmful BRCA1 mutation that is known to increase the lifetime risk of breast and ovarian cancer significantly.

Transitioning from a full-time 911 police dispatcher and mother of two boys to a full-time patient, Holleigh began treatment just three days later, enduring six months of chemotherapy and four rounds of immunotherapy.

March 20th marked a pivotal moment as she underwent a bilateral mastectomy with immediate reconstruction, utilizing expanders. A week later, the news of clear cancer margins brought relief. However, her recovery took an unexpected turn. Admitted on April 1 for an infection at drainage sites, and later, on April 18th, for 11 days due to an infection in her left breast, Holleigh faced the emotional challenge of having the expander removed, leaving her flat.

Despite the unexpected setbacks, May 18th saw her embark on 16 rounds of radiation, concluding treatments on June 12, officially earning the title of a cancer survivor. Being a carrier of the BRCA1 gene, Holleigh planned surgery in September to remove her ovaries and fallopian tubes, aiming to reduce the risk of ovarian cancer.

Reflecting on her journey, Holleigh acknowledged the tough days, the ups and downs, but today she stands alive, well, and a testament to surviving cancer. Encouraging others facing a similar path, she advocates for living as normally as possible during treatment, seeking support, and holding onto the promise of brighter days ahead. The road ahead involves more surgeries, a personal choice, to reconstruct her breasts and continue embracing life beyond the challenges of breast cancer.

The research funded by Breast Cancer Canada focuses on improving techniques for breast cancer screening and detection. With your support, we can know more about breast cancer. And that helps us detect it earlier and treat it better for patients like Holleigh.
Condensed copy for use on social:

Diagnosed with stage 3 triple-negative breast cancer, Holleigh’s journey included a long list of surgeries, treatments and unexpected setbacks. As a BRCA1 carrier, Holleigh now advocates for breast cancer prevention and early detection. She is also a strong believer of holding a sense of normalcy during treatment and embracing life beyond her breast cancer diagnosis.

Despite challenges, Holleigh concluded her treatment on June 12, officially earning the title of a cancer survivor.

The research funded by Breast Cancer Canada focuses on improving techniques for breast cancer screening and detection. With your support, we can know more about breast cancer. And that helps us detect it earlier and treat it better for patients like Holleigh.

More Patient Stories

Laura Montgomery

At just 30 years old, Laura Montgomery heard the words no one ever wants to hear: “You have breast cancer.”

What began as a routine shower turned into a life-altering discovery—she found a lump that didn’t feel right. Laura trusted her instincts and saw a doctor, but, worried that she wouldn’t be taken seriously because of her age, she exaggerated her symptoms just to be heard. The doctor initially believed it was likely nothing but sent her for an ultrasound. That scan changed everything. It revealed what was likely breast cancer—a 1.5 cm tumor.

Steph

After receiving her FIRST mammogram at the age of 40, Steph was diagnosed with DCIS in July 2022. Although she could not feel a lump or disfiguration in her breast, her doctor sent her proactively in hopes of staying on top of the disease.

Brad Whitelaw

Although rare, male breast cancer is a significant health concern – accounting for approximately 1% of all breast cancer cases each year. Despite its rarity, the impact of a male breast cancer diagnosis can be life-altering, often presenting unique challenges due to late detection and limited research.

Cynthia Cushia

“My journey is what I like to call ‘My Gift Wrapped in Barbed Wire”, shares Cynthia. In 2017, Cynthia Cushia, a 37-year old with unwavering tenacity for life, received an unsettling diagnosis: Stage 2, Grade 3 HER2+ breast cancer.

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.